SCHEMBL29856013

SCHEMBL29856013

Cn1ccc2c(Br)cc(C(=O)O)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.44
RHEB Q15382 2/20 0.42
TPMT P51580 2/20 0.39
KDM4E B2RXH2 2/20 0.37
THRA P10827 2/20 0.37
THRB P10828 2/20 0.37
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35
TUBB2A Q13885 1/20 0.35
TUBB8 Q3ZCM7 1/20 0.35
TUBA3E Q6PEY2 1/20 0.35
TUBA1A Q71U36 1/20 0.35
TUBA1C Q9BQE3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19100569 1.00 TTR (0.44) TTRRHEBTPMTKDM4ETHRA
SCHEMBL20610528 0.85 ALDH1A1 (0.41) RHEBKDM4ETUBB4ATUBBTUBA3C
SCHEMBL348258 0.83 KDM4E (0.48) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29855962 0.83 KDM4E (0.48) KDM4ETUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26581107 0.81 SLC22A12 (0.40) TTRTPMTKDM4ETUBB4ATUBB
SCHEMBL16899563 0.80 RHEB (0.48) TTRRHEBTPMTKDM4ETUBB4A
SCHEMBL21438922 0.80 HCAR3 (0.41) TTRRHEBTPMTKDM4ETHRA
SCHEMBL23809345 0.78 SLC22A12 (0.42) KDM4ETHRATHRBTUBB4ATUBB
SCHEMBL19475816 0.77 MAP3K5 (0.44) KDM4EKDM2BKDM4CHCAR3ALDH1A1
SCHEMBL23217889 0.76 FGFR1 (0.44) TTRRHEBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022166916-A1 SUBSTITUTED HETEROARYL DERIVATIVE, AND COMPOSITION AND USE THEREOF 深圳市塔吉瑞生物医药有限公司 2022-08-11 WO disclosed